| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Mechanism of action. Patent Number: US20210140972A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Methods of identifying signaling modulators of the trimeric TNFa. Patent Number: US10883996B2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2020). Modulation of members of the tnf-superfamily. Patent Number: EP3311167B1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2016). Mechanism of action. Patent Number: WO2016202411A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2023). Modulation of members of the tnf superfamily. Patent Number: CA2987823C. |
|
Patent |
|
| James Philip O'connell; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2022). Modulator Assay. Patent Number: ES2895486T3. |
|
Patent |
|
| James Philip O′Connell; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2025). Complexes between CD40 and compounds comprising benzimidazole moieties. Patent Number: US12474348B2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2022). Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors. Patent Number: US11448655B2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2020). TNF receptor signaling modulator assay. Patent Number: US10705094B2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2016). Modulator assay. Patent Number: WO2016202413A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2023). Methods for identifying compounds that bind to tumour necrosis factor superfamily members and modulate signalling of the receptor. Patent Number: CA2987827C. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2022). Modulator complex. Patent Number: EP3960759A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2021). Modulator assay. Patent Number: EP3311169B1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2022). MARKING FOR THE IDENTIFICATION OF MODULATORS. Patent Number: PL3311169T3. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2023). Method of identifying potential inhibitors of APO TNFα trimers. Patent Number: US11674967B2. |
|
Patent |
|